Cervical clear cell adenocarcinoma
MONDO:0006135A rare morphologic variant of cervical adenocarcinoma composed of clear and hobnail cells. It is associated with in utero exposure to diethylstilbestrol (DES).
Also known as: cervical clear cell adenocarcinoma, cervical clear cell carcinoma, cervix clear cell adenocarcinoma, cervix clear cell carcinoma, cervix uteri clear cell adenocarcinoma, cervix uteri clear cell carcinoma, clear cell adenocarcinoma of cervix, clear cell adenocarcinoma of cervix uteri
2846 clinical trials for this condition and its sub-types, 4 tagged with Cervical clear cell adenocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cervical clear cell adenocarcinoma
-
New drug lorigerlimab takes on Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis phase 2 trial is testing a drug called lorigerlimab in about 80 people with advanced ovarian or clear cell gynecologic cancers that have stopped responding to platinum chemotherapy. Lorigerlimab is a bispecific antibody designed to activate the immune system against tumors. …
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for rare ovarian cancer: immunotherapy combo tested in phase II trial
Disease control Recruiting nowThis phase II trial is testing whether the immunotherapy drug dostarlimab, alone or combined with bevacizumab, can control recurrent gynecological clear cell carcinoma better than standard chemotherapy. About 198 women with this rare cancer type will be randomly assigned to one o…
Phase 2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Rare cervical cancer under the microscope: no treatment, just knowledge
Knowledge-focused Recruiting nowThis study is collecting medical records and lab results from 70 people diagnosed with a rare type of cervical cancer called clear cell carcinoma. Researchers want to understand the cancer's features and molecular profile better. No new treatments or drugs are being tested—this i…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC